Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 201

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 8
Chunk 201
---
ITEM 8. FINANCIAL INFORMATION.

A. Consolidated Statements and Other Financial Information.

See “ Item 18. Financial Statements.”

Legal Proceedings

See “ Item 4. B. Business Overview - Legal
Proceedings.”

Dividend Policy

We have never declared or paid any cash dividends
to our shareholders of our Common Shares, and we do not anticipate or intend to pay cash dividends in the foreseeable future. Payment
of cash dividends, if any, in the future will be at the discretion of our Board, in compliance with applicable legal requirements and
will depend on a number of factors, including future earnings, our financial condition, operating results, contractual restrictions,
capital requirements, business prospects, our strategic goals and plans to expand our business, applicable law and other factors that
our Board may deem relevant.

The BCBCA imposes further restrictions on our
ability to declare and pay dividends.

Payment of dividends may be subject to Canadian
withholding taxes. See “ Item 10. E. Taxation - Material Canadian Federal Income Tax Considerations” for additional information.

B. Significant Changes

Other than as otherwise described in this Annual
Report on Form 20-F and as set forth below, no significant change has occurred in our operations since the date of our financial statements
included in this Annual Report on Form 20-F.

ITEM 9. THE OFFER AND LISTING